Daito Pharmaceutical Co.,Ltd. (TYO:4577)
Japan
· Delayed Price · Currency is JPY 2,094.00
-56.00 (-2.60%)
Mar 10, 2025, 3:30 PM JST
Daito Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 30, 2024 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | May '20 May 31, 2020 | 2019 - 2015 |
| Net Income | 3,782 | 4,218 | 5,076 | 6,720 | 5,873 | 5,595 | Upgrade
|
| Depreciation & Amortization | 4,065 | 3,659 | 3,870 | 3,313 | 3,154 | 2,950 | Upgrade
|
| Loss (Gain) From Sale of Assets | 165 | 165 | 17 | 56 | 315 | 156 | Upgrade
|
| Loss (Gain) From Sale of Investments | -735 | -326 | 87 | -47 | -1 | -134 | Upgrade
|
| Other Operating Activities | -1,129 | -1,111 | -2,405 | -1,820 | -1,955 | -625 | Upgrade
|
| Change in Accounts Receivable | 549 | 2,221 | -1,502 | -3,299 | 2,723 | -3,369 | Upgrade
|
| Change in Inventory | -1,186 | -2,640 | -1,413 | -1,041 | -3,609 | -2,075 | Upgrade
|
| Change in Accounts Payable | -1,133 | 802 | 538 | 22 | -765 | 1,229 | Upgrade
|
| Change in Other Net Operating Assets | 691 | -1,806 | -113 | 466 | -553 | 579 | Upgrade
|
| Operating Cash Flow | 5,076 | 5,182 | 4,155 | 4,370 | 5,182 | 4,306 | Upgrade
|
| Operating Cash Flow Growth | 2.34% | 24.72% | -4.92% | -15.67% | 20.34% | -37.49% | Upgrade
|
| Capital Expenditures | -7,481 | -6,220 | -5,505 | -4,627 | -6,318 | -2,731 | Upgrade
|
| Sale (Purchase) of Intangibles | -178 | -56 | -51 | -106 | -31 | -42 | Upgrade
|
| Investment in Securities | 773 | 335 | - | 256 | 5 | 97 | Upgrade
|
| Other Investing Activities | -8 | 11 | -10 | 77 | 20 | -5 | Upgrade
|
| Investing Cash Flow | -7,601 | -5,930 | -5,566 | -4,400 | -6,324 | -2,681 | Upgrade
|
| Long-Term Debt Issued | - | 4,000 | 3,000 | 1,500 | 2,000 | - | Upgrade
|
| Total Debt Issued | 6,000 | 4,000 | 3,000 | 1,500 | 2,000 | - | Upgrade
|
| Long-Term Debt Repaid | - | -2,029 | -1,638 | -1,444 | -1,713 | -1,851 | Upgrade
|
| Total Debt Repaid | -2,529 | -2,029 | -1,638 | -1,444 | -1,713 | -1,851 | Upgrade
|
| Net Debt Issued (Repaid) | 3,471 | 1,971 | 1,362 | 56 | 287 | -1,851 | Upgrade
|
| Issuance of Common Stock | - | - | 302 | 1,527 | 1,798 | 2,008 | Upgrade
|
| Repurchase of Common Stock | -1,174 | -1,176 | -110 | - | - | - | Upgrade
|
| Dividends Paid | -940 | -907 | -931 | -660 | -658 | -502 | Upgrade
|
| Other Financing Activities | -185 | -71 | -7 | 66 | -3 | -5 | Upgrade
|
| Financing Cash Flow | 1,172 | -183 | 616 | 989 | 1,424 | -350 | Upgrade
|
| Foreign Exchange Rate Adjustments | 10 | 51 | 20 | 48 | 5 | -9 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 1 | 1 | 1 | 1 | -2 | Upgrade
|
| Net Cash Flow | -1,343 | -879 | -774 | 1,008 | 288 | 1,264 | Upgrade
|
| Free Cash Flow | -2,405 | -1,038 | -1,350 | -257 | -1,136 | 1,575 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | -51.66% | Upgrade
|
| Free Cash Flow Margin | -5.08% | -2.21% | -2.99% | -0.59% | -2.33% | 3.50% | Upgrade
|
| Free Cash Flow Per Share | -155.80 | -66.15 | -85.29 | -16.79 | -75.64 | 111.60 | Upgrade
|
| Cash Interest Paid | 85 | 40 | 13 | 9 | 7 | 11 | Upgrade
|
| Cash Income Tax Paid | 1,262 | 1,265 | 2,411 | 1,924 | 2,088 | 810 | Upgrade
|
| Levered Free Cash Flow | -1,958 | 330.13 | -918 | -406.63 | -2,781 | 2,059 | Upgrade
|
| Unlevered Free Cash Flow | -1,907 | 355.75 | -910.5 | -401 | -2,776 | 2,066 | Upgrade
|
| Change in Net Working Capital | 235 | -539 | 2,482 | 3,086 | 3,278 | 1,462 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.